Title:
新規の抗ＬＩＬＲＢ２抗体および誘導体生成物
Document Type and Number:
Japanese Patent JP2023547380
Kind Code:
A
Abstract:
本開示は、抗ＬＩＬＲＢ２抗体またはその抗原結合性断片、抗ＬＩＬＲＢ２キメラ抗原受容体タンパク質、これをコードする単離ポリヌクレオチド、これを含む医薬組成物、およびこれらの使用を提供する。【選択図】図３
More Like This:
| WO/2007/010853 | METHOD FOR CONTROL OF ELECTROPORATION APPARATUS |
| JPWO2003100064 | New ubiquitin ligase |
| JP2022545226 | Compositions and methods for neurological disorders |
Inventors:
Costa, Maria Jose
stafford, ryan
McCutcheon, Christa
Ma, Jing-Tian
Hong, Gyu Hee
Tian, Hongyu
Son, Anne
Liao, Ex Charlene
stafford, ryan
McCutcheon, Christa
Ma, Jing-Tian
Hong, Gyu Hee
Tian, Hongyu
Son, Anne
Liao, Ex Charlene
Application Number:
JP2023524602A
Publication Date:
November 10, 2023
Filing Date:
October 20, 2021
Export Citation:
Assignee:
Immune-ONC Therapeutics, Inc.
International Classes:
A61K31/7088; C12N15/13; A61K35/17; A61K39/395; A61K45/00; A61K47/68; A61K48/00; A61K49/16; A61P35/00; A61P35/02; A61P43/00; C07K16/28; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/62; C12N15/63; C12P21/08; G01N33/536; G01N33/543; G01N33/574
Attorney, Agent or Firm:
Osamu Yamamoto
Toru Miyamae
Junichi Matsuo
Tsurugi Toshitaka
Toru Miyamae
Junichi Matsuo
Tsurugi Toshitaka